CRAWFORDVILLE, Fla. — Hurricane Helene weakened to a tropical storm over Georgia with maximum sustained winds of 70 mph (110 ...

The gene therapy comes seven years after another research group at the university helped come up with the first FDA approved gene therapy for an inherited disease.

Scientists comment on the FDA approving Cobenfy (KarXT) for schizophrenia. Dr Sameer Jauhar, Senior Clinical Lecturer in Affective Disorders and Psychosis, Consultant Psychiatrist, King’s College, ...

A popular podcast mentioned it earlier this year, sources say, but the FDA suggests users should be aware of unlisted ingredients.

The U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by ...

The study will evaluate the safety, tolerability and pharmacokinetic characteristics of the company's exenatide implant.

Foresta Organics, an Ayurvedic nutraceutical company founded in 2019, is transforming the health and wellness industry with its range of clean-label supplements. Bootstrapped by entrepreneurs Kirti ...

Paliperidone extended-release tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg have an estimated market size of $48 million for 12 ...

The combined entity will have a stronger financial profile, enhanced R&D capabilities, and a streamlined supply chain, allowing it to serve global pharmaceutical clients more effectively ...

Bristol-Myers Squibb won Food and Drug Administration approval late Thursday for its novel schizophrenia drug, Cobenfy. BMY ...

FRIDAY, Sept. 27, 2024 (HealthDay News) -- The first new type of medication in decades to help fight against schizophrenia ...

(Alliance News) - PureTech Health PLC on Friday said KarXT has received US Food & Drug Administration approval for treating schizophrenia.